Kimberly Manhard

Kimberly Manhard

Director/Board Member bei INHIBRX, INC.

Vermögen: 66 294 $ am 31.03.2024

64 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Kimberly Manhard

EinheitArt der EinheitIndustrie
30
Subsidiary Pharmaceuticals: Major 30
Public Company Biotechnology 30
Public Company Pharmaceuticals: Major 26
Public Company Biotechnology 19
Public Company Pharmaceuticals: Major 10
7
Holding Company Biotechnology 7
5
Holding Company Biotechnology 5
Fleet Science Center
4
Private Company 4

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Kimberly Manhard

UnternehmenSektorVerknüpfte PersonenHauptposition
Pharmaceuticals: Major

John W. Poyhonen

Barry Quart

Michael A. Adam

Colin E. Rowlings

Neil James Clendeninn

John P. Montana

Sales & Marketing

Chief Tech/Sci/R&D Officer

General Counsel

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Wendy Dixon

Michael A. Adam

David Kao

Sales & Marketing

General Counsel

Corporate Officer/Principal

Pharmaceuticals: Major

Paul Blake

Austin Kim

Corporate Officer/Principal

Corporate Secretary

INCYTE CORPORATION Pharmaceuticals: Major

Julian Baker

Edmund Harrigan

Wendy Dixon

James Daly

Director/Board Member

Director/Board Member

Director/Board Member

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Edmund Harrigan

John W. Poyhonen

Barry Quart

Jennifer J. Rhodes

Michael A. Adam

Jeffrey Jensen

Ponni Subbiah

Mark Schneyer

Elizabeth Garofalo

Julie Fisher

General Counsel

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

LA JOLLA PHARMACEUTICAL COMPANY Pharmaceuticals: Major

Kevin Tang

Craig Johnson

Robert H. Rosen

Jeffrey Jensen

Chairman

Director/Board Member

Director/Board Member

Chief Tech/Sci/R&D Officer

IONIS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Kleanthis Xanthopoulos

Katherine Bishop

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Kleanthis Xanthopoulos

Christopher Krueger

Corporate Officer/Principal

General Counsel

BIODELIVERY SCIENCES INTERNATIONAL, INC. Pharmaceuticals: Major

Paul Blake

Kevin Kotler

Chief Tech/Sci/R&D Officer

Director/Board Member

Investment Managers

Felix Baker

Julian Baker

Stephen Biggar

Founder

Founder

Portfolio Manager-Equities

Pharmaceuticals: Major

Marios Fotiadis

Kleanthis Xanthopoulos

Steven Holtzman

Michael A. Adam

Director/Board Member

Founder

Chairman

Corporate Officer/Principal

Pharmaceuticals: Major

William Forbes

John W. Beck

Jeffrey Jensen

General Counsel

Founder

Corporate Officer/Principal

Pharmaceuticals: Major

Barry Quart

Mark Longer

President

Corporate Officer/Principal

GENOMIC HEALTH, INC. Medical Specialties

Felix Baker

Julian Baker

Henry Fuchs

Director/Board Member

Director/Board Member

Director/Board Member

University of Notre Dame College/University

David T. Hagerty

Sandra Coufal

Brendan Teehan

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

BELLICUM PHARMACEUTICALS, INC. Biotechnology

Edmund Harrigan

Stephen Davis

James Daly

Director/Board Member

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Kleanthis Xanthopoulos

Christopher Krueger

Director/Board Member

Corporate Officer/Principal

J.E.M. CAPITAL INC Financial Conglomerates

Kleanthis Xanthopoulos

Christopher Krueger

Director/Board Member

Corporate Secretary

College/University

Julian Baker

Henry Fuchs

David Matly

Undergraduate Degree

Undergraduate Degree

Masters Business Admin

Stanford University College/University

Felix Baker

Matthew Grob

Robert M. Myers

Stephen Biggar

Austin Kim

John Driver

Doctorate Degree

Graduate Degree

Graduate Degree

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

College/University

John W. Beck

John P. Montana

Sharmila Dissanaike

Undergraduate Degree

Undergraduate Degree

Graduate Degree

University of Pennsylvania College/University

Susan Rodriguez

Kevin Kotler

Graduate Degree

Undergraduate Degree

San Diego State University College/University

Sean T. Ristine

Scott Brown

Masters Business Admin

Graduate Degree

New York University College/University

Neil James Clendeninn

Julie Fisher

Doctorate Degree

Undergraduate Degree

Oregon State University College/University

Jeffrey Jensen

Jeffrey Miner

Undergraduate Degree

Doctorate Degree

University of California San Diego College/University

Christopher Krueger

Christian Waage

Brendan Eckelman

William Sandborn

Benir Ruano

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Corporate Officer/Principal

Undergraduate Degree

University of California, Santa Barbara College/University

Esmé c. Smith

Lisa Peraza

Rob Ackles

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

University of Iowa College/University

Doug Forsyth

Colin E. Rowlings

Don Soland

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Investment Trusts/Mutual Funds

Neil James Clendeninn

Kristiina Vuori

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Kleanthis Xanthopoulos

James M. Mackay

Corporate Officer/Principal

Director/Board Member

Investment Managers

Kevin Kotler

Adam Morgan

Chief Executive Officer

Analyst-Equity

REGULUS THERAPEUTICS INC. Pharmaceuticals: Major

Kleanthis Xanthopoulos

David Szekeres

Chief Executive Officer

Director of Finance/CFO

Specialty Stores

Marios Fotiadis

Kleanthis Xanthopoulos

Founder

Founder

IRRAS AB Medical Specialties

Marios Fotiadis

Kleanthis Xanthopoulos

Chairman

Director/Board Member

SIO GENE THERAPIES INC. Pharmaceuticals: Major

Kristiina Vuori

Parag V. Meswani

Julie Fisher

Director/Board Member

Chief Operating Officer

Corporate Officer/Principal

KINIKSA PHARMACEUTICALS, LTD. Pharmaceuticals: Major

Felix Baker

Barry Quart

Stephen Biggar

Director/Board Member

Director/Board Member

Director/Board Member

Investment Managers

Marios Fotiadis

Kleanthis Xanthopoulos

Chairman

Private Equity Investor

Pharmaceuticals: Major

Felix Baker

Barry Quart

Director/Board Member

Director/Board Member

ODONATE, INC. Pharmaceuticals: Major

Kevin Tang

Craig Johnson

Robert H. Rosen

Chief Executive Officer

Director/Board Member

Director/Board Member

VENTYX BIOSCIENCES, INC. Biotechnology

Christopher Krueger

William Sandborn

Corporate Officer/Principal

President

Statistik

International

Vereinigte Staaten 49
Hong Kong 2
Schweden 2

Sektoral

Health Technology 32
Consumer Services 12
Finance 6
Miscellaneous 2
Commercial Services 2

Operativ

Director/Board Member 385
Corporate Officer/Principal 215
Independent Dir/Board Member 140
Undergraduate Degree 79
Founder 57
  1. Börse
  2. Insiders
  3. Kimberly Manhard
  4. Unternehmensverbindungen